Therefore, we hypothesized that miR-191-5p directly targets DAPK1 and influences the PI3K/AKT signaling pathway through its regulatory effects on p53 and CDKN2A in T2DM. The gene discussed is TP53; the disease is type 2 diabetes mellitus.